Cellarity
Colin Diner has a strong background in scientific research, with work experience at various institutions. Colin began their career as a Visiting Researcher at the University of Erlangen-Nuremberg in 2014. Subsequently, they worked as a Postdoctoral Researcher at Stockholm University and the University of Ottawa. In 2018, they joined Paraza Pharma Inc. as a Scientist before being promoted to Senior Scientist. Currently, they hold the position of Senior Scientist II at Cellarity, where they were recently appointed as Principal Scientist in 2023.
Colin Diner earned a Bachelor of Science in Chemistry from the University of Wisconsin-Madison in 2009. Colin later completed their Doctor of Philosophy in Organic Chemistry at the University of Alberta in 2015.
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.